Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ONEBRIEF, INC. via CGCN GROUP, LLC
2026 · third_quarter · Q3
Issues related to technology in the defense industry.
Issues related to technology in the defense industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MANUS BIO INC. via
Source: Senate LDA
2026 · third_quarter · Q3
Issues pertaining to onshoring of biotechnology manufacturing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
MANUS BIO INC. via CGCN GROUP, LLC
2026 · second_quarter · Q2
Issues pertaining to onshoring of biotechnology manufacturing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
ONEBRIEF, INC. via CGCN GROUP, LLC
2026 · second_quarter · Q2
Issues related to technology in the defense industry.
Issues related to technology in the defense industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MANUS BIO INC. via CGCN GROUP, LLC
2026 · first_quarter · Q1
Issues pertaining to onshoring of biotechnology manufacturing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
ONEBRIEF, INC. via CGCN GROUP, LLC
2026 · first_quarter · Q1
Issues related to technology in the defense industry.
Issues related to technology in the defense industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ONEBRIEF, INC. via CGCN GROUP, LLC
2025 · fourth_quarter · Q4
Issues related to technology in the defense industry.
Issues related to technology in the defense industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MANUS BIO INC. via CGCN GROUP, LLC
2025 · fourth_quarter · Q4
Issues pertaining to onshoring of biotechnology manufacturing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
ONEBRIEF, INC. via CGCN GROUP, LLC
2025 · third_quarter · Q3
Issues related to technology in the defense industry.
Issues related to technology in the defense industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MANUS BIO INC. via CGCN GROUP, LLC
2025 · third_quarter · Q3
Issues pertaining to onshoring of biotechnology manufacturing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
MANUS BIO INC. via CGCN GROUP, LLC
2025 · second_quarter · Q2
Issues pertaining to onshoring of biotechnology manufacturing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
MANUS BIO INC. via CGCN GROUP, LLC
2025 · third_quarter · RR
Issues pertaining to onshoring of biotechnology manufacturing.
ONEBRIEF, INC. via CGCN GROUP, LLC
2025 · second_quarter · Q2
Issues related to technology in the defense industry.
Issues related to technology in the defense industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE